Skip to content

ORTHOTM Sera Papain 6904840Recalls & reported problems

Alba Bioscience Limited · For in vitro diagnostic use only. For use as an enzyme solution with ORTHO™ Sera Anti-Lea, Anti-Leb, Anti-Jka and Anti-Jkb Blood Grouping Reagents. The ORTHO™ Sera Papain is used to enhance reactivity of ORTHO™ Sera red blood cell antigen typing reagents and red blood cells when used in in vitro immunohematology assays. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10758750030330), received between May 23, 2023 and Jun 25, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Expiration Date Error” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Expiration Date Error1
  • Insufficient Device Problem Information1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 25, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    THE END USER REPORTS FALSE NEGATIVE RESULTS WITH ORTHO SERA PAPAIN PRODUCT FD317, LOT V278742, EXPIRY 30SEP25.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22327432 ↗
  • MalfunctionMay 23, 2023Expiration Date Error; Expiration Date Error

    END USER REPORTS A FALSE NEGATIVE RESULT WITH ORTHOSERA PAPAIN PRODUCT FD317 LOT V249596 EXPIRY 06MAY23. THE END USER REPORTS EIGHT DONOR SAMPLES GENERATED FALSE NEGATIVE AND WEAK POSITIVE RESULTS WITH THE REAGENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16984021 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page